Thanks, Paul. As a reminder, a more detailed report of my remarks on the financial results can be found on the investor relations section of our website. Right now, I will cover a few key metrics. First quarter non-GAAP gross profit as a percent of revenue increased to 31.8% in fiscal 2015 from 31.4% a year ago. First quarter non-GAAP selling, general and administrative expenses as a percent of revenue, excluding commissions to our nonemployee experts, was 19.0% in Q1 fiscal 2015 compared with 18.8% a year ago. In terms of headcount, we ended the first quarter with 461 consulting staff which consisted of 354 senior staff and 107 junior staff. This is a net increase of 10 consultants from the 451 we reported at the end of Q4 of fiscal 2014. While this growth in headcount was not as high as we would have liked during the first quarter, our candidate pipeline is strong and we continue to be active in the recruiting market. As Paul mentioned, the performance of the life sciences team in Germany has exceeded our plan. This success has led to a revision of our estimated future contingent consideration payments associated with the acquisition of this team, resulting in a $800,000 charge in this current quarter. The effective tax rate for the first quarter of fiscal 2015 on a non-GAAP basis was 32.7%, compared with 36.4% for the first quarter of fiscal 2014, reflecting the geographical mix of our earnings. Turning to the balance sheet, our DSO at the end of the first quarter was 100 days, consisting of 62 days of billed and 38 days of unbilled. In terms of our cash position, we concluded the first quarter of fiscal 2015 with approximately $17.2 million of cash and cash equivalents. Q1 is typically a period of lower cash levels as bonus outlays for the Firm occur during this time. We also continued our practice of redeploying cash both into the business operations and towards the repurchase of equity. During the first quarter, we purchased approximately 145,000 shares of our common stock for a total of approximately $4.5 million. Furthermore, as we announced on our Q4 earnings call in February, our Boston and Washington, DC, offices are currently undergoing renovations to create a more efficient and welcoming workplace. The related cash outlays totaled approximately $2 million in Quarter 1, with further expenditures expected to continue throughout fiscal 2015. As we discussed in our prior earnings call, we anticipate total expenditures for these locations to be approximately $12 million, net of tenant improvement allowances, in fiscal 2015. That concludes our prepared remarks. Manny, we would now like to open up the call for questions.